Pancreatic Cancer Research

ResearcherCedars-Sinai Medical CenterActive in the last 2 years

Yan Ou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-0098-0394; OpenAlex author ID A5102215744. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 4

  1. Specific targeting of cancer cell mitochondria with a malaria drug improves pancreatic cancer outcome. Co-author DOI 10.1038/s41598-026-66961-9↗
  2. Significantly higher incidence of circulating fatty objects in portal blood samples compared to peripheral blood samples in patients with pancreatic ductal ade… Co-author DOI 10.3389/fonc.2025.1611872↗
  3. HDAC4/MybL1/YAP novel signaling axis is required for pancreatic cancer metastasis to the liver. Co-author DOI 10.7150/ijbs.102132↗
  4. Novel DZ-SIM Conjugate Targets Cancer Mitochondria and Prolongs Survival in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/adtp.202200021↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Stephen Jacob Pandol · 4 shared papers, 2022–2026 · strength 0.90
  2. Mouad Edderkaoui · 4 shared papers, 2022–2026 · strength 0.90
  3. Ruoxiang Wang · 3 shared papers, 2022–2026 · strength 0.69
  4. Omer Hany Miligy Elmadbouh · 2 shared papers, 2022–2025 · strength 0.37
  5. Simon K. Lo · 1 shared paper, 2025 · strength 0.23
  6. Rabindra R. Watson · 1 shared paper, 2025 · strength 0.23
  7. Srinivas Gaddam · 1 shared paper, 2025 · strength 0.23
  8. Neil A. Bhowmick · 1 shared paper, 2025 · strength 0.21
  9. Dina Hauptschein · 1 shared paper, 2025 · strength 0.21
  10. Raul A. Urrutia · 1 shared paper, 2025 · strength 0.21
  11. Arsen Osipov · 1 shared paper, 2025 · strength 0.21
  12. Ramachandran Murali · 1 shared paper, 2025 · strength 0.21
  13. Yi Zhang · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.